Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1994-09-07
1996-10-22
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530326, 435 5, C07K 14435
Patent
active
055678050
ABSTRACT:
The present invention relates to methods of inhibiting HIV-mediated cell killing which comprises inhibiting the interaction between the CS3 region and viral gp41 and its receptor on the surface of lymphocytes. The invention provides for methods which employ peptides, peptide derivatives, or antibodies to inhibit the CS3/CS3 receptor interaction. In addition, the invention also relates to the CS3 receptor.
The present invention is based in part on the discovery that a CS3 specific cellular receptor is widely distributed on human lymphocytes and forms a 108 kd complex with CS3-HSA peptide conjugate. It was further discovered that CS3 peptide effectively blocks HIV mediated cell infection and killing. Therefore, the present invention provides for methods of treatment and prophylaxis of HIV infection as well as a means for better understanding the physiology of acquired immunodeficiency syndrome (AIDS).
REFERENCES:
patent: 4822606 (1989-04-01), Snyderman et al.
Tsudo et al, PNAS. USA. 83. 9694-9698. 1986.
Garry, Aids, 3.(11).683-694(1989).
Gartner et al., Science 233:215-219 (1986).
Wainberg et al., Immunol. 54:1 (1985).
Pahwa et al., Proc. Nat'l Acad. Sci. 82:8198-8202 (1985).
Nair et al., Proc. Nat'l Acad. Sci. USA 85:6498-6502 (1988).
Sodroski et al., Nature 322:470-474 (1986).
Lifson et al., Nature 323:725-728 (1986).
Stevenson et al., Cell 53:483-496 (1988).
Smith et al., Science 238:1704-1707 (1987).
Fisher et al., Nature 331:76-78 (1988).
Lifson et al., Science 241:712-716 (1988).
Nara et al., Proc. Nat'l Acad, Sci. USA 86:7139-7143 (1989).
Hayashi et al., Arch. Virol. 105:129-135 (1989).
Chao et al., J. Biol. Chem. 264:5812-5817 (1989).
Billich et al., J. Biol. Chem. 263:17905-17908 (1988).
Moore et al., Biochem. Biophys. Res. Commun. 159:420-425 (1989).
Moore et al., Immunopharmacol. 16:181-189 (1988).
Cauda et al., Cell Immunol. 115:57-65 (1988).
Ruegg et al., J. Virol. 63:3257-3260 (1989).
Chanh et al., Cell Immunol. 111:77-86 (1988).
Cianciolo et al., Immunol. Lett. 19:7-14 (1988).
Rusche et al., Proc. Nat'l Acad. Sci. USA 85:3198-3208 (1988).
Dalgleish et al. Virology 165:209-215 (1988).
Dalgleish et al., UCLA Symposia on Mol. & Cell. Biochem. Supp. 13B at p. 288 (1989).
Starcich et al., Cell 45:637-648 (1986).
Klutzman and Gluckman, Immunol. Today 7:291-296 (1986).
Klasse et al., Proc. Nat'l Acad. Sci. USA 85:5225-5229 (1988).
Tenin, Rev. Inf. Dis. 10:399-405 (1988).
Fisher et al., Science 233:655-659 (1986).
Coy David H.
Garry, Jr. Robert F.
Henderson Lee A.
Administrators of the Tulane Educational Fund
Nucker Christine M.
Stucker Jeffrey
LandOfFree
The cellular receptor for the CS3 peptide of human immunodeficie does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The cellular receptor for the CS3 peptide of human immunodeficie, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The cellular receptor for the CS3 peptide of human immunodeficie will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2359452